Preventing Pathogenic Dimerization in a Misfolded Antibody Light Chain through the Design of an Inhibitory Peptide
The Journal of Physical Chemistry B · 2026
DOI: 10.1021/acs.jpcb.5c07238 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Physical Chemistry B, 2026. Verfasst von Fausta Desantis und 4 weiteren Autor:innen. Beteiligte Einrichtung: Istituto Italiano di Tecnologia (IIT), Center for Life Nano and Neuro Science, Viale Regina Elena 291, Roma 00161, Italy. Hauptthemen laut MEDLINE: Peptides, Immunoglobulin Light Chains, Protein Multimerization. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: HORIZON EUROPE European Innovation Council, Ministero dell?Istruzione, dell?Universit? e della Ricerca, NextGenerationEU.
Abstract (Originalsprache)
Immunoglobulin light chain (AL) amyloidosis is the most common form of systemic amyloidosis. The disease correlates with the formation of insoluble aggregates mostly composed of patient-specific antibody light chains, whose hypervariable regions make each case unique and highlight the need for personalized therapeutics. In this study, we focused on a pathogenic homodimer we previously obtained from a patient-derived light chain. By analyzing the dynamics and the interface of this dimer, we identified a peptide with potential inhibitory activity. The peptide was then refined using a computational mutagenesis protocol that iteratively improved its sequence to maximize complementarity with the protein interface, taking into account shape, electrostatics, and hydropathy. The resulting optimized peptide is found to bind the monomer with a binding affinity comparable to that of the full pathogenic interface. These results suggest that the designed peptide could act as an effective antagonist of the pathogenic dimer, and demonstrate that our computational strategy could provide a general framework for designing patient-specific inhibitory peptides against aggregation-prone proteins.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Istituto Italiano di Tecnologia (IIT), Center for Life Nano and Neuro Science, Viale Regina Elena 291, Roma 00161, Italy.
- Sapienza University of Rome, Department of Physics, Piazzale Aldo Moro, 5, Rome 00185, Italy.
- Link Campus University, Via del Casale di San Pio V, 44 00165, Rome Italy.
- Department of Biochemical Sciences "Alessandro Rossi Fanelli", Sapienza University of Rome, P.le A. Moro 5, 00185 Rome, Italy.
ORCID-Profile: Mattia Miotto, Edoardo Milanetti, Lorenzo Di Rienzo
Förderung
- HORIZON EUROPE European Innovation Council
- Ministero dell?Istruzione, dell?Universit? e della Ricerca
- NextGenerationEU
- H2020 European Research Council
Zitieren
APA
Desantis, F., Miotto, M., Milanetti, E., Ruocco, G., & Di Rienzo, L. (2026). Preventing Pathogenic Dimerization in a Misfolded Antibody Light Chain through the Design of an Inhibitory Peptide. The Journal of Physical Chemistry B. https://doi.org/10.1021/acs.jpcb.5c07238
Vancouver
Desantis F, Miotto M, Milanetti E, Ruocco G, Di Rienzo L. Preventing Pathogenic Dimerization in a Misfolded Antibody Light Chain through the Design of an Inhibitory Peptide. The Journal of Physical Chemistry B. 2026. doi:10.1021/acs.jpcb.5c07238
BibTeX
@article{Desantis2026,
author = {Desantis, Fausta and Miotto, Mattia and Milanetti, Edoardo and Ruocco, Giancarlo and Di Rienzo, Lorenzo},
title = {Preventing Pathogenic Dimerization in a Misfolded Antibody Light Chain through the Design of an Inhibitory Peptide},
journal = {The Journal of Physical Chemistry B},
year = {2026},
doi = {10.1021/acs.jpcb.5c07238}
}
EUVIMED